Similar articles

• Apraclonidine and LASIK.

  Aslanides IM, Tsiklis NS, Pallikaris IG, Jankov MR, Coskunseven E, Ozkilic E. Aslanides IM, et al. Ophthalmology. 2005 Dec;112(12):2238; author reply 2244. doi: 10.1016/j.ophtha.2005.09.021. Ophthalmology. 2005. PMID: 16325717 Clinical Trial. No abstract available.
• Subconjuctival hemorrhages after LASIK. Laser in situ keratomileusis.

  Dada T, Sharma N, Vaypayee RB, Dada VK. Dada T, et al. J Cataract Refract Surg. 2000 Nov;26(11):1570-1. doi: 10.1016/s0886-3350(00)00725-2. J Cataract Refract Surg. 2000. PMID: 11185595 No abstract available.
• Effect of prophylactic topical brimonidine (0.15%) administration on the development of subconjunctival hemorrhage after intravitreal injection.

  Kim CS, Nam KY, Kim JY. Kim CS, et al. Retina. 2011 Feb;31(2):389-92. doi: 10.1097/IAE.0b013e3181eef28e. Retina. 2011. PMID: 20890238 Clinical Trial.
• Thin-flap laser-assisted in situ keratomileusis.

  Slade SG. Slade SG. Curr Opin Ophthalmol. 2008 Jul;19(4):325-9. doi: 10.1097/ICU.0b013e328302cc77. Curr Opin Ophthalmol. 2008. PMID: 18545016 Review.
• Posterior segment complications of laser in situ keratomileusis (LASIK).

  Mirshahi A, Baatz H. Mirshahi A, et al. Surv Ophthalmol. 2009 Jul-Aug;54(4):433-40. doi: 10.1016/j.survophthal.2009.04.008. Surv Ophthalmol. 2009. PMID: 19539831 Review.